{"DataElement":{"publicId":"5211051","version":"1","preferredName":"Ovarian Carcinoma Histologic Primary Classification Type","preferredDefinition":"The type of tumor submitted/identified upon slide review.","longName":"OVR_HX_PRI_CLASS_TYP","context":"BBRB","contextVersion":"1","DataElementConcept":{"publicId":"5210572","version":"1","preferredName":"Ovarian Carcinoma Histologic Primary Classification","preferredDefinition":"information relating to the histologic primary classification of ovarian carcinoma._","longName":"3304105v1.0:2430074v1.0","context":"BBRB","contextVersion":"1","ObjectClass":{"publicId":"3304105","version":"1","preferredName":"Ovarian Carcinoma","preferredDefinition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms. --2002","longName":"C4908","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Carcinoma","conceptCode":"C4908","definition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1C9C115-8BEA-6AED-E040-BB89AD43131A","latestVersionIndicator":"Yes","beginDate":"2011-11-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-11-15","modifiedBy":"ONEDATA","dateModified":"2011-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2430074","version":"1","preferredName":"Histologic Primary Classification","preferredDefinition":"Of or relating to histology.:Occurring first in time or sequence; original. (American Heritage Dictionary):Classification; the grouping of things into classes or categories.","longName":"C25526:C25251:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05B23066-8F5E-1D7B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-17","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-17","modifiedBy":"ONEDATA","dateModified":"2005-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB61077-1130-C33A-E050-BB89AD437DA5","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"HARTLEYG","dateModified":"2016-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5210573","version":"1","preferredName":"Ovarian Carcinoma Histologic Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"5210573v1.0","context":"BBRB","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other - specify","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C4E8-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Other sex cord-stromal tumor (WHO code: 8590/1)","valueDescription":"OV-STR - 183; Ovary-Stromal","ValueMeaning":{"publicId":"2572679","version":"1","preferredName":"OV-STR - 183; Ovary-Stromal","longName":"2572679","preferredDefinition":"A benign or malignant neoplasm that arises from the ovary and is composed of granulosa cells, Sertoli cells, Leydig cells, theca cells, and fibroblasts.  Representative examples include thecoma, fibroma, Sertoli cell tumor, and granulosa cell tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Sex Cord-Stromal Tumor","conceptCode":"C4862","definition":"A benign or malignant neoplasm that arises from the ovary and is composed of granulosa cells, Sertoli cells, Leydig cells, theca cells, and fibroblasts.  Representative examples include thecoma, fibroma, Sertoli cell tumor, and granulosa cell tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E8F4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-01-05","modifiedBy":"LUY","dateModified":"2015-02-24","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/24/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C4FC-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Undifferentiated carcinoma (WHO code: 8020/3)","valueDescription":"Undifferentiated Ovarian Carcinoma","ValueMeaning":{"publicId":"5210913","version":"1","preferredName":"Undifferentiated Ovarian Carcinoma","longName":"5210913","preferredDefinition":"An aggressive carcinoma arising from the ovary.  Most patients present with advanced disease.  Microscopically, it is characterized by significant cytologic atypia, increased mitotic activity, and necrosis.  The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Undifferentiated Carcinoma","conceptCode":"C4509","definition":"An aggressive carcinoma arising from the ovary.  Most patients present with advanced disease.  Microscopically, it is characterized by significant cytologic atypia, increased mitotic activity, and necrosis.  The prognosis is usually poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C509-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C522-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Transitional cell carcinoma (WHO code: 8120/3)","valueDescription":"Ovarian Transitional Cell Carcinoma","ValueMeaning":{"publicId":"5210915","version":"1","preferredName":"Ovarian Transitional Cell Carcinoma","longName":"5210915","preferredDefinition":"A carcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that resemble malignant urothelial cells.  There is no morphologic evidence of a benign or borderline Brenner tumor component present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Transitional Cell Carcinoma","conceptCode":"C5240","definition":"A carcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that resemble malignant urothelial cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C52F-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C548-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Transitional cell borderline carcinoma (WHO code: 8120/1)","valueDescription":"Borderline Ovarian Transitional Cell Tumor","ValueMeaning":{"publicId":"5210916","version":"1","preferredName":"Borderline Ovarian Transitional Cell Tumor","longName":"5210916","preferredDefinition":"An ovarian epithelial neoplasm that resembles the transitional cell neoplasms found in the urinary tract. It is characterized by the presence of atypia and absence of stromal invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Transitional Cell Tumor","conceptCode":"C40088","definition":"An ovarian epithelial neoplasm that resembles the transitional cell neoplasms found in the urinary tract. It is characterized by the presence of atypia and absence of stromal invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C554-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C56D-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Squamous cell carcinoma","valueDescription":"Ovarian Squamous Cell Carcinoma","ValueMeaning":{"publicId":"5210918","version":"1","preferredName":"Ovarian Squamous Cell Carcinoma","longName":"5210918","preferredDefinition":"A usually high grade squamous cell carcinoma that arises from the ovary and is not associated with a germ cell tumor.  The prognosis is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Squamous Cell Carcinoma","conceptCode":"C40093","definition":"A usually high grade squamous cell carcinoma that arises from the ovary and is not associated with a germ cell tumor.  The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C57A-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C593-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Serous cystadenocarcinoma (WHO code: 8441/3)","valueDescription":"Ovarian Serous Cystadenocarcinoma","ValueMeaning":{"publicId":"5210920","version":"1","preferredName":"Ovarian Serous Cystadenocarcinoma","longName":"5210920","preferredDefinition":"A malignant serous cystic epithelial neoplasm arising from the ovary.  It is characterized by the presence of glandular, papillary, or solid structures.  Psammoma bodies may be present.  In well differentiated cases the malignant epithelial cells resemble the cells of fallopian tube epithelium.  In poorly differentiated cases the malignant epithelial cells show anaplastic features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Serous Cystadenocarcinoma","conceptCode":"C7978","definition":"A malignant serous cystic epithelial neoplasm arising from the ovary.  It is characterized by the presence of glandular, papillary, or solid structures.  Psammoma bodies may be present.  In well differentiated cases the malignant epithelial cells resemble the cells of fallopian tube epithelium.  In poorly differentiated cases the malignant epithelial cells show anaplastic features.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C5A0-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C5B9-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Serous carcinoma (WHO: 8441/3)","valueDescription":"Ovarian Serous Adenocarcinoma","ValueMeaning":{"publicId":"3248525","version":"1","preferredName":"Ovarian Serous Adenocarcinoma","longName":"3248525","preferredDefinition":"Ovarian serous adenocarcinoma is a serous neoplasm characterized by nuclear atypia, high mitotic activity, stratification, glandular complexity, branching papillary fronds and stromal invasion. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Serous Adenocarcinoma","conceptCode":"C7550","definition":"An adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that, in well differentiated tumors, resemble the epithelium of the fallopian tube or, in poorly differentiated tumors, show anaplastic features and marked nuclear atypia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-B901-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C5CD-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Serous borderline tumor (WHO code: 8441/1)","valueDescription":"Borderline Ovarian Serous Tumor","ValueMeaning":{"publicId":"3247932","version":"1","preferredName":"Borderline Ovarian Serous Tumor","longName":"3247932","preferredDefinition":"A low grade serous epithelial neoplasm arising from the ovary.  It is characterized by an atypical proliferation of serous-type epithelial cells without evidence of stromal invasion.  It is often asymptomatic but rarely it may present with abdominal pain or abdominal enlargement due to rupture or torsion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Serous Tumor","conceptCode":"C5226","definition":"A low grade serous epithelial neoplasm arising from the ovary.  It is characterized by an atypical proliferation of serous-type epithelial cells without evidence of stromal invasion.  It is often asymptomatic but rarely it may present with abdominal pain or abdominal enlargement due to rupture or torsion.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67BAD06-6F8F-ACFF-E040-BB89AD437FAC","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C5E1-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Mucinous cystadenocarcinoma (WHO code: 8470/3)","valueDescription":"Ovarian Mucinous Cystadenocarcinoma","ValueMeaning":{"publicId":"5210922","version":"1","preferredName":"Ovarian Mucinous Cystadenocarcinoma","longName":"5210922","preferredDefinition":"An invasive cystic adenocarcinoma arising from the ovary.  It is characterized by the presence of malignant glandular epithelial cells which contain intracytoplasmic mucin.  The malignant cells invade the ovarian stroma and the cystic spaces contain mucoid material.  In a minority of cases both ovaries are involved by the tumor.  The prognosis for stage I tumors is excellent.  Patients with metastases usually have a poor prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Mucinous Cystadenocarcinoma","conceptCode":"C4026","definition":"An invasive cystic adenocarcinoma arising from the ovary.  It is characterized by the presence of malignant glandular epithelial cells which contain intracytoplasmic mucin.  The malignant cells invade the ovarian stroma and the cystic spaces contain mucoid material.  In a minority of cases both ovaries are involved by the tumor.  The prognosis for stage I tumors is excellent.  Patients with metastases usually have a poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C5EE-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C607-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Mucinous carcinoma (WHO code: 8480/3)","valueDescription":"Ovarian Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"5210924","version":"1","preferredName":"Ovarian Mucinous Adenocarcinoma","longName":"5210924","preferredDefinition":"An invasive adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that contain intracytoplasmic mucin.  There is cellular atypia, increased layering of cells, complexity of glands, and papillary formations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Mucinous Adenocarcinoma","conceptCode":"C5243","definition":"An invasive adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that contain intracytoplasmic mucin.  There is cellular atypia, increased layering of cells, complexity of glands, and papillary formations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C614-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C62D-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Mucinous borderline tumor, intestinal type (WHO code: 3472/1)","valueDescription":"Borderline Ovarian Mucinous Tumor, Intestinal Type","ValueMeaning":{"publicId":"5210926","version":"1","preferredName":"Borderline Ovarian Mucinous Tumor, Intestinal Type","longName":"5210926","preferredDefinition":"A neoplasm of low malignant potential arising from the ovary.  It is characterized by the proliferation of neoplastic mucinous epithelial cells that resemble intestinal epithelial cells.  There is no evidence of stromal invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Mucinous Tumor, Intestinal Type","conceptCode":"C40037","definition":"A neoplasm of low malignant potential arising from the ovary.  It is characterized by the proliferation of neoplastic mucinous epithelial cells that resemble intestinal epithelial cells.  There is no evidence of stromal invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C63A-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C653-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Mucinous borderline tumor, endocervical (seromuninous) type (WHO code: 8472/1)","valueDescription":"Borderline Ovarian Mucinous Tumor, Endocervical-Like","ValueMeaning":{"publicId":"5210928","version":"1","preferredName":"Borderline Ovarian Mucinous Tumor, Endocervical-Like","longName":"5210928","preferredDefinition":"A neoplasm of low malignant potential arising from the ovary.  It is characterized by the proliferation of neoplastic epithelial cells that resemble endocervical epithelial cells.  There is no evidence of stromal invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Mucinous Tumor, Endocervical-Like","conceptCode":"C40038","definition":"A neoplasm of low malignant potential arising from the ovary.  It is characterized by the proliferation of neoplastic epithelial cells that resemble endocervical epithelial cells.  There is no evidence of stromal invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C660-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C679-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Mixed epithelial carcinoma (8323/3)","valueDescription":"Ovarian Seromucinous Carcinoma","ValueMeaning":{"publicId":"5210929","version":"1","preferredName":"Ovarian Seromucinous Carcinoma","longName":"5210929","preferredDefinition":"A malignant mixed epithelial neoplasm that arises from the ovary and is composed predominantly of serous and endocervical-type mucinous epithelium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Seromucinous Carcinoma","conceptCode":"C40090","definition":"A malignant mixed epithelial neoplasm that arises from the ovary and is composed predominantly of serous and endocervical-type mucinous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C683-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C69C-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Mixed epithelial borderline tumor (WHO code: 8323/1)","valueDescription":"Borderline Ovarian Mixed Epithelial Tumor","ValueMeaning":{"publicId":"3247936","version":"1","preferredName":"Borderline Ovarian Mixed Epithelial Tumor","longName":"3247936","preferredDefinition":"A low grade ovarian epithelial tumor composed of an admixture of two or more of the five major cell types: serous, mucinous, endometrioid, clear cell, and Brenner/transitional.  The second or second and third cell types must comprise alone or together at least 10% of the tumor epithelium. The majority of patients present with stage I tumor and a minority present with bilateral disease. Morphologically, it shows papillae with detached cell clusters.  Microinvasion may be seen rarely. (WHO 2003)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor","conceptCode":"C7281","definition":"A low grade, non-invasive ovarian epithelial neoplasm characterized by the presence of atypical neoplastic serous and mucinous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67BAD06-6FDB-ACFF-E040-BB89AD437FAC","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C6B0-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Malignant germ cell tumor (WHO code: 9064/3)","valueDescription":"Malignant Ovarian Germ Cell Tumor","ValueMeaning":{"publicId":"5210930","version":"1","preferredName":"Malignant Ovarian Germ Cell Tumor","longName":"5210930","preferredDefinition":"An invasive malignant neoplasm that arises from the ovary and originates from primordial germ cells.  Representative examples include embryonal carcinoma, yolk sac tumor, dysgerminoma, and non-gestational choriocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Ovarian Germ Cell Tumor","conceptCode":"C4514","definition":"An invasive malignant neoplasm that arises from the ovary and originates from primordial germ cells.  Representative examples include embryonal carcinoma, yolk sac tumor, dysgerminoma, and non-gestational choriocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C6BA-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C6D3-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Granulosa cell tumor (WHO code 8620/1)","valueDescription":"Ovarian Granulosa Cell Tumor","ValueMeaning":{"publicId":"5210932","version":"1","preferredName":"Ovarian Granulosa Cell Tumor","longName":"5210932","preferredDefinition":"A granulosa-stromal cell tumor that arises from the ovary.  It is characterized by the presence of granulosa cells that comprise at least ten percent of the cellular population.  The granulosa cells are often found in a background that contains theca and fibrous cells.  There are two major subtypes recognized, adult and juvenile granulosa cell tumor.  Clinically, patients may present with an abdominal mass.  Symptoms depend on the patient's age.  The most important indicator of prognosis is tumor stage.  Age over forty years at the time of the initial diagnosis, large tumor size, bilaterality, cellular atypia, and increased mitotic activity are factors indicating a potentially aggressive clinical course and relative poor prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Granulosa Cell Tumor","conceptCode":"C6261","definition":"A granulosa-stromal cell tumor that arises from the ovary.  It is characterized by the presence of granulosa cells that comprise at least ten percent of the cellular population.  The granulosa cells are often found in a background that contains theca and fibrous cells.  There are two major subtypes recognized, adult and juvenile granulosa cell tumor.  Clinically, patients may present with an abdominal mass.  Symptoms depend on the patient's age.  The most important indicator of prognosis is tumor stage.  Age over forty years at the time of the initial diagnosis, large tumor size, bilaterality, cellular atypia, and increased mitotic activity are factors indicating a potentially aggressive clinical course and relative poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C6E0-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C6F9-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Endometrioid carcinoma (WHO code: 8380/3)","valueDescription":"Ovarian Endometrioid Adenocarcinoma","ValueMeaning":{"publicId":"5210934","version":"1","preferredName":"Ovarian Endometrioid Adenocarcinoma","longName":"5210934","preferredDefinition":"An endometrioid adenocarcinoma arising from the ovary.  It comprises 10% to 25% of all primary ovarian carcinomas.  Grossly, endometrioid carcinoma may present as a cystic or solid mass.  Microscopically, the tumor greatly resembles the appearance of the ordinary type of endometrial adenocarcinoma.  As a group, endometrioid carcinoma has a prognosis twice as good as that of serous or mucinous carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Endometrioid Adenocarcinoma","conceptCode":"C7979","definition":"An endometrioid adenocarcinoma arising from the ovary.  It comprises 10% to 25% of all primary ovarian carcinomas.  Grossly, endometrioid carcinoma may present as a cystic or solid mass.  Microscopically, the tumor greatly resembles the appearance of the ordinary type of endometrial adenocarcinoma.  As a group, endometrioid carcinoma has a prognosis twice as good as that of serous or mucinous carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C706-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"TSESU","dateModified":"2023-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C71F-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Endometrioid borderline tumor (WHO code: 8380/1)","valueDescription":"Borderline Ovarian Endometrioid Tumor","ValueMeaning":{"publicId":"3247945","version":"1","preferredName":"Borderline Ovarian Endometrioid Tumor","longName":"3247945","preferredDefinition":"A neoplasm of low malignant potential arising from the ovary. It is characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells. The surrounding ovarian stroma is often fibrotic. There is no evidence of stromal invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor","conceptCode":"C7983","definition":"An epithelial neoplasm that arises from the ovary characterized by the presence of glandular or cystic spaces which contain atypical glandular epithelial cells resembling endometrial cells. The surrounding ovarian stroma is often fibrotic. There is no evidence of stromal invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67BAD06-70D6-ACFF-E040-BB89AD437FAC","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C733-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Clear cell carcinoma (WHO code: 8310/3)","valueDescription":"Clear Cell Adenocarcinoma","ValueMeaning":{"publicId":"4039074","version":"1","preferredName":"Clear Cell Adenocarcinoma","longName":"4039074","preferredDefinition":"A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Adenocarcinoma","conceptCode":"C3766","definition":"A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFFA5EA-68A2-E8CD-E040-BB89AD4345DA","latestVersionIndicator":"Yes","beginDate":"2014-01-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C747-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Clear cell borderline tumor (WHO code: 8310/1)","valueDescription":"Borderline Ovarian Clear Cell Tumor","ValueMeaning":{"publicId":"3247942","version":"1","preferredName":"Borderline Ovarian Clear Cell Tumor","longName":"3247942","preferredDefinition":"An epithelial neoplasm with low malignant potential affecting the ovary.  It is characterized by the presence of clear or hobnail cells.  In some cases, the cells may display nuclear atypia and prominent nucleoli.  When such cells are present, they remain confined to the glands.  There is no evidence of stromal invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Clear Cell Tumor","conceptCode":"C40080","definition":"An epithelial neoplasm with low malignant potential affecting the ovary.  It is characterized by the presence of clear or hobnail cells.  In some cases, the cells may display nuclear atypia and prominent nucleoli.  When such cells are present, they remain confined to the glands.  There is no evidence of stromal invasion.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67BAD06-708D-ACFF-E040-BB89AD437FAC","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC1F18F-C75B-E402-E050-BB89AD436C18","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Carcinosarcoma (Malignant mullerian mixed tumor) (WHO code: 8950/3)","valueDescription":"Carcinosarcoma (Malignant mullerian mixed tumor) (WHO code: 8950/3)","ValueMeaning":{"publicId":"5210574","version":"1","preferredName":"Carcinosarcoma (Malignant mullerian mixed tumor) (WHO code: 8950/3)","longName":"5210574","preferredDefinition":"A malignant tumor composed of a mixture of carcinomatous and sarcomatous elements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinosarcoma","conceptCode":"C34448","definition":"A malignant tumor composed of a mixture of carcinomatous and sarcomatous elements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB697C7-E5CD-4E5E-E050-BB89AD436E5D","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FB697C7-E5E6-4E5E-E050-BB89AD436E5D","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Brenner Tumor, malignant type (WHO code: 9000/3)","valueDescription":"Malignant Ovarian Brenner Tumor","ValueMeaning":{"publicId":"3120341","version":"1","preferredName":"Malignant Ovarian Brenner Tumor","longName":"3120341","preferredDefinition":"A Brenner tumor of the ovary characterized by a cytologically malignant cell population and stromal invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Ovarian Brenner Tumor","conceptCode":"C4270","definition":"A malignant neoplasm that arises from the ovary. It is characterized by the presence of an invasive malignant urothelial-type cellular component and nests of benign urothelial-type cells in a fibrotic stroma. When the neoplasm is confined to the ovary, the prognosis is good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AEE1D01-2AD5-F246-E040-BB89AD433010","latestVersionIndicator":"Yes","beginDate":"2010-07-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-07-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FB697C7-E5FA-4E5E-E050-BB89AD436E5D","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FB697C7-E5B7-4E5E-E050-BB89AD436E5D","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"HARTLEYG","dateModified":"2016-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736426","version":"1","longName":"Ovary Local Path Review","context":"BBRB"}]}],"AlternateNames":[{"name":"BBRB","type":"USED_BY","context":"BBRB"}],"ReferenceDocuments":[{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"BBRB"}],"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2FC458DB-D6B3-736D-E050-BB89AD437860","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"HARTLEYG","dateModified":"2019-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}